18 reports

Pulmonary Drug Delivery Devices market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Pulmonary Drug Delivery Devices Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Pulmonary Drug Delivery Devices types,...

  • Pulmonary Delivery
  • World

Pulmonary Drug Delivery Systems market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Pulmonary Drug Delivery Systems Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Pulmonary Drug Delivery Systems types,...

  • Drug Delivery
  • Pulmonary Delivery
  • World

Pulmonary Drug Delivery Systems Market by Product (Dry Powder Inhaler, Metered Dose Inhaler and Nebulizers), Application (Asthma, Chronic Obstructive Pulmonary Diseases (COPD), and Cystic Fibrosis), and Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and E-Commerce): Global Opportunity Analysis and Industry Forecast,...

  • Drug Delivery
  • Pulmonary Delivery
  • Respiratory Device
  • World
  • APAC

Pulmonary Drug Delivery Systems Market Report Overview Pulmonary Drug Delivery Systems market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Pulmonary Drug Delivery Systems market types and applications. It is a focused study on Pulmonary...

  • Drug Delivery
  • Pulmonary Delivery
  • World
  • Health Provider Density

Pulmonary Drug Delivery Devices Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026 The study predicts the short term and long term trends that can shape up the future of the Pulmonary Drug Delivery Devices market including the COVID-19...

  • Pulmonary Delivery
  • APAC
  • Central America

KEY FINDINGS The global pulmonary drug delivery market is anticipated to register a CAGR of 5.06%, during the forecast years of 2019 to 2028. The key drivers, such as advancements in technology, the surging prevalence of respiratory diseases, and the rising geriatric population, are attributed to market growth. MARKET...

  • Drug Delivery
  • Pulmonary Delivery
  • Respiratory Disease
  • World
  • APAC

Pulmonary Drug Delivery Devices Market Size, Outlook and Growth Opportunities, 2019- 2025 Global Pulmonary Drug Delivery Devices Market Size, Outlook and Growth Opportunities to 2025: By Product Type( Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, and Accessories), By Sales Channel( Retail Pharmacies, Hospital...

  • Pulmonary Delivery
  • World
  • APAC
  • Asia
  • Europe
  • North America
  • Middle East
  • Africa
  • Latin America
  • Health Expenditure

KEY FINDINGS The Asia Pacific pulmonary drug delivery market is estimated to grow with a CAGR of 6.50%, over the forecast period of 2019 to 2028. The rising levels of pollutions leading to respiratory conditions, potential growth opportunities within the medical devices division, and supportive government initiatives are...

  • Pulmonary Delivery
  • Medical Device
  • APAC
  • India
  • Life Expectancy

KEY FINDINGS The Europe pulmonary drug delivery market is evaluated to generate a CAGR of 4.62%, during the forecast period of 2019 to 2028. The increased mortality rates due to lung cancer and chronic obstructive pulmonary disease (COPD), and the rising government expenditure to battle respiratory diseases are primary...

  • Respiratory Disease
  • Pulmonary Delivery
  • Europe
  • France
  • Hospital Admission
  • Tobacco Consumption

KEY FINDINGS The North America pulmonary drug delivery market is estimated to harbor a CAGR of 4.40%, during the forecast years of 2019 to 2028. The primary factors propelling the market growth include, advanced technology and affordability, the increased geriatric population, and the rising prevalence of lifestyle-related...

  • Pulmonary Delivery
  • Respiratory Disease
  • North America
  • Canada

This study covers the world outlook for pulmonary drug delivery systems across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...

  • Drug Delivery
  • Pulmonary Delivery
  • World
  • Gross Domestic Product
  • Disposable Income

This study covers the world outlook for pulmonary drug delivery technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...

  • Pulmonary Delivery
  • World
  • Gross Domestic Product
  • Disposable Income

Global Pulmonary Drug Delivery Devices Market: Overview The pulmonary route of administration has proven to be effective in local and systemic delivery of miscellaneous drugs and biopharmaceuticals to treat pulmonary and non-pulmonary diseases.Inhalation therapy is the best option to treat to treat lung diseases such as...

  • Pulmonary Delivery
  • World

Report Scope: This report will provide a detailed look at the pulmonary drug delivery systems market, highlighting major pulmonary diseases with detailed epidemiology for major disease areas such as asthma, COPD and cystic fibrosis. The report includes an industry-wide assessment of the novel products, launches, recent...

  • Drug Delivery
  • Pulmonary Delivery
  • World

This study covers the latent demand outlook for pulmonary drug delivery systems across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,600 cities in the United States. For each city in question, the percent share the city...

  • Drug Delivery
  • Pulmonary Delivery
  • United States
  • Disposable Income
  • Purchasing Power Parity

This study covers the latent demand outlook for pulmonary drug delivery systems across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and Tianjin), special administrative regions (Hong Kong and Macau), and Taiwan (all hereafter...

  • Drug Delivery
  • Pulmonary Delivery
  • China
  • Disposable Income
  • Purchasing Power Parity

Pulmonary Drug Delivery Devices/Systems Market Analysis By Product (MDIs, DPIs, Nebulizers, Accessories), By Application, By Distribution Channel, By End-use, And Segment Forecasts, 2014 - 2025 The global pulmonary drug delivery devices/systems market is expected to reach USD 55.1 billion by 2025, according to a new report by Grand...

  • Pulmonary Delivery
  • Respiratory Disease
  • World
  • APAC
  • Chronic Obstructive Pulmonary Disease Prevalence

The global pulmonary drug delivery market is projected to reach USD 52.37 billion by 2021 from USD 36.10 billion in 2016, at a CAGR of 6.5% during the forecast period. Increasing preference of pulmonary route as an alternate route of drug delivery, rising focus on the development of smart/digital inhalers and increasing incidence of respiratory...

  • Pulmonary Delivery
  • World
  • United States
  • North America
  • Europe
  • Asia
  • United Kingdom
  • Chronic Obstructive Pulmonary Disease Prevalence
  • Smoking Prevalence